Insider Sells 1,649 Progressive Shares at $204.35 as Analysts Cut Targets
Insider Andrew Quigg sold 1,649 shares on January 21 at an average of $204.35, trimming his stake by 4% to 39,626 shares. Brokerages cut price targets on Progressive, with JPMorgan lowering its target from $303 to $275 and UBS from $268 to $261.
1. Insider Transaction Signals Reduced Stake
Progressive insider Andrew Quigg divested 1,649 shares on January 21, generating proceeds of approximately $337,000. Post-sale, his holdings declined by 4.0% to 39,626 shares, valued at roughly $8.1 million. This significant insider sale may prompt investors to reassess near-term confidence levels among senior executives, particularly given the concentrated ownership stake and the timing relative to recent quarterly disclosures.
2. Dividend Policy and Shareholder Yield
On January 8, Progressive distributed a quarterly dividend of $0.10 per share, translating to an annualized payout of $0.40 and a yield near 0.2%. The company’s dividend payout ratio stands at just over 2%, reflecting ample retained earnings for growth initiatives. With the ex-dividend date having passed on January 2, investors seeking modest income should note Progressive’s conservative cash return approach and strong capital position.
3. Institutional Positioning and Analyst Sentiment
Major institutional holders have marginally increased stakes: Vanguard added 151,240 shares in Q3, while State Street boosted its position by 78,374 shares. Capital International’s third-quarter accumulation of over 6 million shares marked the largest institutional scale-up. Meanwhile, analysts remain cautious—seven rate the shares a Buy, thirteen a Hold and two a Sell, resulting in a consensus Hold rating. Recent target adjustments from firms including JPMorgan, UBS and BMO reflect lowered outlooks, underscoring tempered growth expectations within the insurance sector.